HiFiBiO, Pharmsynthez and IBCh sign Covid-19 antibody development deal
HFB30132A is engineered with specific sequences identified from the B cells of a Covid-19 convalescent patient. Credit: visuals3Dde from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more
